Página 5 - Melhores Quimioterapia médicos - TOP-147 médicos

O Professor Cicin possui mais de 20 anos de experiência em oncologia, com especialização em quimioterapia, e atende no İstinye University Liv Hospital Topkapı.

• Certificado em oncologia médica desde 2004
• Formação de especialização (Fellowship) concluída na Faculdade de Medicina da Universidade Trakya
• Professor de Oncologia Médica na Universidade Trakya
• Pesquisador publicado na área de tratamentos oncológicos

Mais de 30 anos de prática especializada – O Dr. Weidmann chefia o setor de Hematologia na Clínica Nordwest.

• Especialista no tratamento de distúrbios sanguíneos, particularmente linfoma não Hodgkin
• É titular de um professorado em hematologia
• Lidera uma equipe dedicada em uma clínica reconhecida

O Professor Associado Tarik Salman é especialista em tratamentos personalizados contra o câncer no Hospital Internacional Medicalpoint, incluindo o perfil genômico abrangente.

• Mais de 15 anos de experiência em oncologia médica
• Treinado no Memorial Sloan Kettering Cancer Center
• Membro do conselho de múltiplas associações de oncologia
• Especialista em terapias direcionadas e imunoterapia

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

O Professor Associado Muhammed Mustafa Atci lidera o programa de Oncologia Médica no İstinye University Liv Hospital Topkapı, com extensa pesquisa sobre os resultados da quimioterapia.

• Especialista em oncologia médica com foco em protocolos de quimioterapia
• Publicou múltiplos estudos sobre a eficácia da quimioterapia em periódicos revisados por pares
• Membro da Sociedade Americana de Oncologia Clínica (ASCO)
• Coordenador de Educação para a Subdivisão de Oncologia Médica

Diretor Clínico de uma Unidade de Mama Multidisciplinar com 322 publicações revisadas por pares – O Dr. Kuemmel lidera a pesquisa de câncer de mama na Kliniken Essen-Mitte.

• Membro do Conselho Executivo da AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)
• Membro do corpo docente da ESMO para Câncer de Mama
• PI Global e chefe de 27 investigações e ensaios clínicos
• Membro de múltiplas sociedades oncológicas de prestígio, incluindo ESMO e ASCO

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Assoc. Prof. Dr. Mehmet Salih İyikesici is a medical oncologist. He provides personalized care for breast, lung, and gastrointestinal cancers. He combines metabolically supported therapies with chemotherapy. His interests include the ketogenic diet in cancer care, hyperthermia, and hyperbaric oxygen therapy.

He has conducted and contributed to national and international scientific studies. Selected national peer-reviewed publications include Metabolic Supported Chemotherapy in Rectal Cancer (2020), NSCLC Patient Outcomes – Marmara University (2004), and Early-Stage Breast Cancer Outcomes (2004).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

O Dr. Prat lidera a SOLTI como presidente, concebendo ensaios clínicos para tratamentos de câncer de mama. Sua pesquisa se concentra na expressão gênica e em subtipos moleculares.

• Chefe de Genômica Translacional e Terapias-Alvo no IDIBAPS
• Cofundador da Reveal Genomics, detentor de três patentes
• Mais de 160 publicações com um Índice H de 51
• Fellowship em oncologia médica no Vall d´Hebron Institute of Oncology
• Professor Adjunto Tenure-Track na Universidade de Barcelona

Especialista de referência em leucemia linfocítica crónica (LLC) – O Professor Bosch foi pioneiro em novos tratamentos e tecnologias para doenças hematológicas.

• Conduz mais de 80 ensaios clínicos da fase 1 à fase 3
• Publicou mais de 100 artigos nas principais revistas médicas
• Chefe de Hematologia no IOB Institute of Oncology
• Presidente do Grupo Espanhol para o Estudo da LLC (GELLC)

Investigadora Principal em ensaios clínicos para câncer de ovário, cervical e endometrial – a Dra. Oaknin lidera pesquisas inovadoras no Hospital Quiron Barcelona.

• Autora de mais de 100 publicações sobre tumores ginecológicos
• Membro do conselho executivo do Grupo GEICO (Grupo Espanhol de Pesquisa sobre Câncer de Ovário)
• Membro do corpo docente (Faculty member) para o Gyn-Track na ESMO
• Representante espanhola no Comitê Cervical do Grupo GCIG

Especializa-se em tratamentos de câncer de mama e melanoma, com foco na resistência à terapia hormonal e na imunoterapia. Trabalha no Hospital Quirón Barcelona.

• Participou em ensaios clínicos que levaram à aprovação de novos medicamentos para o câncer de mama
• Envolvido(a) em estudos que revolucionaram o tratamento do melanoma
• Membro das Unidades de Câncer de Mama e Melanoma em Vall d’Hebron
• Foca-se no cuidado integral (holístico) do paciente

O Dr. Graus é um especialista de referência em síndromes neurológicas paraneoplásicas, tendo definido os primeiros critérios diagnósticos rigorosos para estas condições.

• Mais de 40 anos de experiência em neuro-oncologia
• Antigo Chefe de Neurologia no Hospital Clinic Barcelona
• Fundador e ex-presidente da Associação Europeia de Neuro-Oncologia
• Especializado em neurotoxicidades resultantes de tratamentos oncológicos
• Doutoramento Honorário pela Universidade de Lyon